Stock Scorecard



Stock Summary for Kamada Ltd (KMDA) - $6.83 as of 3/28/2025 12:19:33 AM EST

Total Score

19 out of 30

Safety Score

30 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for KMDA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for KMDA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for KMDA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for KMDA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for KMDA (30 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 7
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 2
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for KMDA

Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer 3/27/2025 8:30:00 AM
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer 3/27/2025 8:30:00 AM
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer - Alvotech ( NASDAQ:ALVO ) 3/27/2025 8:30:00 AM
Alvotech Reports Record Results for 2024 and Provides Business Update 3/26/2025 10:36:00 PM
Alvotech Reports Record Results for 2024 and Provides Business Update 3/26/2025 10:34:00 PM
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® ( omalizumab ) 3/26/2025 8:30:00 AM
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® ( omalizumab ) 3/26/2025 8:30:00 AM
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® ( omalizumab ) - Alvotech ( NASDAQ:ALVO ) 3/26/2025 8:30:00 AM
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders - Kamada ( NASDAQ:KMDA ) 3/24/2025 11:00:00 AM
Alvotech Acquires Xbrane's R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production - Alvotech ( NASDAQ:ALVO ) 3/20/2025 7:00:00 AM

Financial Details for KMDA

Company Overview

Ticker KMDA
Company Name Kamada Ltd
Country USA
Description Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2024
Next Earnings Date 5/6/2025

Stock Price History

Last Day Price 6.83
Price 4 Years Ago 6.39
Last Day Price Updated 3/28/2025 12:19:33 AM EST
Last Day Volume 39,979
Average Daily Volume 176,555
52-Week High 8.90
52-Week Low 4.61
Last Price to 52 Week Low 48.16%

Valuation Measures

Trailing PE 28.75
Industry PE 37.01
Sector PE 40.10
5-Year Average PE -25.44
Free Cash Flow Ratio 5.02
Industry Free Cash Flow Ratio 11.91
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 3.73
Total Cash Per Share 1.36
Book Value Per Share Most Recent Quarter 4.51
Price to Book Ratio 1.57
Industry Price to Book Ratio 8.86
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 2.53
Industry Price to Sales Ratio Twelve Trailing Months 88.85
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 57,505,000
Market Capitalization 392,759,150
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/17/2025
Previous Dividend Amount 0.0000
Current Dividend Amount 0.2000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.20
Trailing Annual Dividend Yield 2.93%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 1
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 83.33%

Income Statement

Quarterly Earnings Growth YOY -18.60%
Annual Earnings Growth 74.58%
Reported EPS 12 Trailing Months 0.24
Reported EPS Past Year 0.26
Reported EPS Prior Year 0.15
Net Income Twelve Trailing Months 14,462,000
Net Income Past Year 14,462,000
Net Income Prior Year 8,284,000
Quarterly Revenue Growth YOY 7.10%
5-Year Revenue Growth 4.82%
Operating Margin Twelve Trailing Months 13.00%

Balance Sheet

Total Cash Most Recent Quarter 78,435,000
Total Cash Past Year 78,435,000
Total Cash Prior Year 55,641,000
Net Cash Position Most Recent Quarter 78,435,000
Net Cash Position Past Year 65,472,000
Long Term Debt Past Year 12,963,000
Long Term Debt Prior Year 12,963,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.95
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 259,464,000
Total Stockholder Equity Prior Year 244,021,000
Total Stockholder Equity Most Recent Quarter 259,464,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 36,598,251
Free Cash Flow Per Share Twelve Trailing Months 0.64
Free Cash Flow Past Year 36,854,000
Free Cash Flow Prior Year -1,535,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.01
MACD Signal -0.03
20-Day Bollinger Lower Band 5.23
20-Day Bollinger Middle Band 6.54
20-Day Bollinger Upper Band 7.85
Beta 0.21
RSI 49.14
50-Day SMA 5.12
150-Day SMA 0.00
200-Day SMA 5.24

System

Modified 3/28/2025 12:19:34 AM EST